Table 5b.
Inferior Hypopharynx Dose (Gy) |
||||
---|---|---|---|---|
≤ 50 | 51–60 | > 60 | ||
Tumor Site | Oral cavity/oropharynx | 20/57 (35%) | 4/10 (40%) | 7/7 (100%) |
Larynx/hypopharynx | 7/11 (64%) | 7/17 (41%) | 26/52 (50%) | |
T Stage | T1/T2 | 9/26 (35%) | 2/7 (29%) | 5/11 (45%) |
T3/T4 | 18/42 (43%) | 9/20 (45%) | 28/48 (58%) |